Delivery Order SPE2DR25D9901-SPE2DR26FMLN8
Award Date 3/25/26
Potential Completion Date 3/26/26
Potential Value $3.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 25, 2026, for diazepam injection, with a ceiling value of $3,795.00 and an ultimate completion date of March 26, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a DLA single-award indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support military healthcare...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,854.80 delivery order to DMS Pharmaceutical Group Inc. on December 30, 2025, for diazepam injection under firm fixed pricing. DMS Pharmaceutical Group Inc. is a woman-owned small business. The delivery order is issued under the company's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion governmentwide...
- The Defense Logistics Agency issued a $2,381.61 delivery order to DMS Pharmaceutical Group Inc. on March 18, 2026, for diazepam 10 mg/2 ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order carries a firm fixed price and an ultimate completion date of March 18, 2026. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract vehicle supporting...
- The Defense Logistics Agency's Medical Supply Chain division issued a $1,854.80 delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, for diazepam injection. The order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place...
- <p>The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for diazepam 50 mg/10 ml vials with a ceiling value of $4,535.68, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of March 9, 2026. No set-aside was used.</p>
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,082.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Diazepam 10mg/2ml in quantities of 10 units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and represents a non-set-aside procurement. DMS Pharmaceutical Group will perform work at its facility in Park...
- The U.S. Defense Logistics Agency, operating through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for diazepam injection on September 17, 2025, with a ceiling value of $3,772.80. This firm fixed-price delivery order represents a single purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026. The SPE2DB indefinite delivery vehicle enables the Defense...
- The Defense Logistics Agency issued a $3,795 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 25, 2026, for diazepam injection under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge, IL. The order carries a firm...
- <p>The Defense Logistics Agency issued a $3,338.64 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for diazepam 10 mg/2 ml carpuject 2 ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, Illinois. Ultimate completion date is March 9, 2026. The order is firm fixed price with no set-aside.</p>
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,082.55 to DMS Pharmaceutical Group Inc. for the supply of Diazepam 10mg/2ml in quantities of 10 units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this work at its Park Ridge facility with an ultimate completion date of February 9, 2026. This delivery order was issued without a set-aside designation, demonstrating the...